Antimicrobial prophylaxis for transrectal ultrasound guided biopsy of prostate: a comparative study between single dose of Gentamicin vs. Ofloxacin  by Chazan, B. et al.
trac
m
d
5
U
i
M
t
l
r
A
i
b
e
p
f
d
b
I
7
o
i
d
w
s
R
1
a
2
X
p
s
A
t
d
o
d
5
A
g
s
B
n
W14th International Congress on Infectious Diseases (ICID) Abs
50.002
Impact of restriction policy as part of an antimicrobial
stewardship program in a university hospital of a devel-
oping country
P. Titanti, V. Berdin˜as, J. Ramos, L. Manevich, L. Barcelona,
P. Rios, G. Lopardo ∗
Hospital B Houssay, Buenos Aires, Argentina
Background: In an era of growing concern about bacte-
rial resistance and hospital costs, limiting the use of broad
spectrum antibiotics is important. The purpose of this study
is to evaluate the impact of restriction policy as part of an
antimicrobial stewardship program.
Methods: The study was conducted in a 140-bed univer-
sity hospital of a developing country. Tools of the program
were development of guidelines of antimicrobial therapy
for common community and hospital-acquired infections and
education to improve antimicrobial prescription. During the
ﬁrst period of the program we implemented a policy of
prior approval for selected antibiotics. Every day pharma-
cists reviewed prescriptions and the team discussed with
prescribing physicians to accomplish with hospital guide-
lines. After one year of implementation of the program,
we stopped the restriction policy and we kept on working
with the other tools of the program. To assess if cessation
of restriction was associated with an increase in antimi-
crobial consumption, we measured antibiotic consumption
during the ﬁrst year (period 1) and during one year after
we stopped restriction (period 2). Antimicrobial consump-
tion was measured by Deﬁned Daily Dose (DDD) normalized
by 1000 bed-days.
Results: During the period 2 antibiotic consumption
of ceftriaxone, ceftazidime and vancomycin decreased;
it remained unchanged for piperacillin-tazobactam while
cefepime, imipenem and colsitin increased
Period 1 Period 2 Percentage
of Increase/
Decrease (%)
P value
Antibiotic DDD per
1000
beddays
Cefepime 53,73 80,97 +50,7 <0.01
Ceftazidime 17,56 12,57 -28,4 <0.01
Ceftriaxone 40,00 32,07 -19,8 <0,01
Colistin 9,25 19,50 +110,8 <0,01
Imipenem 14,11 21,65 +53,4 <0,01
Piperacillint-
azobactam
30,36 30,19 -0,05 0,9
Vancomycin 44,31 36,98 -16,5 <0,01
Conclusion: Antibiotic consumption of 4 out of 7 agents
did not increased after we stopped restriction policy, while
some agents suffered an increased; these agents were those
mainly prescribed in intensive care unit associated to an
increase in isolation of multidrug resistant Acinetobacter sp.
Programs aimed to improve antibiotic prescription accom-
panied by measurement of antibiotic consumption may help
to focus the program in some particular agents and areas of
the hospital, and also to reinforce other infection control
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easures.
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tilization of activated protein C (Xigris) in a large teach-
ng hospital- Possible overuse and complications
.R. Wallace, C. Arinyedokiari ∗, B. Dattani
Orlando Health, Orlando, FL, USA
Background: The role of drotrecogin alpha (Xigris) in the
reatment of septic shock remains controversial. The recent
iterature suggests there is little or no beneﬁt, and deﬁnite
isk, for patients whose APACHE II scores are less than 25.
2007 Cochrane analysis stated that the beneﬁt of Xigris
n patients with higher APACHE II scores was supported only
y ‘‘very weak evidence’’. We reviewed our institutional
xperience with this agent.
Methods: Retrospective evaluation of the records of 73
atients receiving Xigris at an 808-bed teaching hospital
rom April 2003 to June 2008. APACHE II scores, demographic
ata, clinical outcomes, 28-day mortality, and incidence of
leeding complications were assessed.
Results: Forty-ﬁve of 73 (61%) patients had an APACHE
I score ≥25. The overall incidence of bleeding was 18 of
3 (25%); in 8 cases, severe or life-threatening bleeding
ccurred. Six of 18 (33%) patients with bleeding during the
nfusion had APACHE II scores < 25, with 4 of those 6 cases
escribed as severe. The 28-daymortality among all patients
as 25 of 73 (34%), with 19 of 25 (76%) having APACHE II
cores ≥25 and 6 of 25 (24%) having APACHE II scores < 25.
elative to the APACHE II scores, the 28-day mortality was
9 of 45(42%) among patients with an APACHE II score ≥25
nd 6 of 28 (21%) among patients with an APACHE II score <
5.
Conclusion: Thirty-nine percent of patients receiving
igris had APACHE II scores less than 25; its value in these
atients is unproven. The incidence of bleeding during infu-
ion of this drug is signiﬁcant and is associated with higher
PACHE II scores, but severe bleeding occurred even among
hose with lower APACHE II values, who were less likely to
erive any beneﬁt from its use. Xigris may be signiﬁcantly
ver utilized, and its use is not without risk.
oi:10.1016/j.ijid.2010.02.1929
0.004
ntimicrobial prophylaxis for transrectal ultrasound
uided biopsy of prostate: a comparative study between
ingle dose of Gentamicin vs. Oﬂoxacin
. Chazan ∗, G. Zelichenko, Y. Shental, H. Edelstein, R. Raz
Ha Emek Medical Center, Afula, Israel
Background: Prostate cancer is the most common malig-
ancy in men, and has been increasing in incidence in the
estern world. The gold standard for diagnosing prostate
ancer is a transrectal US-guided biopsy. One of the com-
lications of this procedure is the development of urinary
ract infections. It has been shown that treatment with pro-
hylactic antibiotics prior to the procedure reduces the rate
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importance of this study is that tigecycline may be a
therapeutic option for chronic osteomyelitis resistant Acine-
tobacter sp, under which treatment options are very limited.
doi:10.1016/j.ijid.2010.02.1932200 14
f infections. The widespread use of quinolones for this and
ther reasons has led to an increase in resistant bacteria.
ims of this study: to evaluate the efﬁcacy of single-dose
entamicin in comparison with single dose of oﬂoxacin in
atients underwent transrectal ultrasound guided biopsy of
rostate.
Methods: 109 patients undergoing a prostate biopsy were
andomly assigned to two groups: the ﬁrst group was treated
ith a single dose of oﬂoxacin (400mg) prior to the biopsy
nd the second with a single dose of gentamicin (3mg/kg).
linical signs and symptoms, and urine tests and cultures
ere followed 2 and 7 days after procedure.
Results: 57 patients received Oﬂoxacin and 52 Gentam-
cin. 3 patients in the Oﬂoxacin group (5.2%) and 4 in the
entamicin group (7.6%) developed urinary tract infections
N.S). No diferences were seen in the clinical outcome
etween the groups.
Conclusion: The development of quinolone resistant
acteria has led us to examine alternative options for pro-
hylactic treatment before prostate biopsies. Gentamicin,
as as efﬁcient as quinolones in the prevention of urinary
ract infections. A single dose prior to the procedure is suf-
cient and longer treatment duration is unnecessary.
oi:10.1016/j.ijid.2010.02.1930
0.005
educing inappropriate antibiotic usage and costs in
n academic Hematology-Oncology unit via antimicrobial
tewardship
.L. Yeo ∗, T.S. Wu, R. Lim, P.A. Tambyah, L.Y. Hsu
National University Health System, Singapore, Singapore
Background: Rising consumption of broad spectrum
ntimicrobials and increasing prevalence of resistant
athogens have raised concerns about antimicrobial use
n recent years. Antimicrobial stewardship programs have
een reported to improve patient and institutional outcomes
hile potentially reducing cost and resistance rates. In the
ight of these ﬁndings, an antimicrobial stewardship program
ASP) was initiated in a tertiary care hospital in Singapore.
Methods: The program was initiated in July 2009
nd piloted in the haematology-oncology department. A
rospective audit and feedback mechanism was employed
or review of patients on selected broad spectrum antimi-
robials. Appropriateness for use was assessed based on
ndication of therapy, dose of antimicrobials used, and dura-
ion of therapy. Recommendations were made by infectious
isease physicians to the primary team in writing. Appropri-
teness of use, recommendations made, patient savings and
linical outcomes were analyzed for a period of four months
fter initiation of the program.
Results: A total of 462 cases were reviewed of which 64%
f them were appropriate. The most commonly prescribed
ntimicrobials were piperacillin/tazobactam, ceftazidime
nd imipenem, making up 19%, 16% and 15% of the cases
udited respectively. Among the recommendations made,
e-escalation and discontinuation of antimicrobials were the
ost common, eachmaking up 27% of the recommendations.
his was followed by recommendations for IV-to-PO switch
nd advice on treatment duration, which made up 11% ofternational Congress on Infectious Diseases (ICID) Abstracts
he recommendations each. The overall acceptance rate of
he recommendations was 89%. An estimate of the potential
atient savings due to the accepted recommendations came
p to $24, 590 over the four months period. There was no
igniﬁcant negative impact on clinical outcomes following
he recommendations.
Conclusion: ASP has demonstrated its impact in reduc-
ng unnecessary use of broad spectrum antimicrobials and
ost to patients. Extension of the program is likely to reduce
election pressure for drug-resistant pathogens in the insti-
ution and decrease antimicrobial expenditure.
oi:10.1016/j.ijid.2010.02.1931
0.006
igecycline usage in osteomielitis caused by multidrug-
esistent acinetobacter: A report of 10 cases from a single
nstitution
.M. Ruiz1, E. Gayoso2,∗, Y. Vasquez3
Hospital militar, Caracas, DC, Venezuela
Hospital Millitar, caracas, DC, Venezuela
Hospital Militar Dr. carlos Arvelo, Caracas, DC, Venezuela
Background: Acinetobacter infectious has been identiﬁed
n soldiers who participated in wars as Korean, Vietnam and
iddle Orient, by now the therapeutics options are limited
or this type of multidrug resistant microorganism, we know
hat the use is not approved for de treatment a bone infec-
ious, so we found necessary to evaluate the efﬁcacy of
igecycline in the treatment of this entity.
Methods: We identiﬁed 10 patients with chronic
steomielitis during 2007-2008, this study of cases is
rospective, descriptive analytical, we use the microbio-
ogical method of Kirby-Bauer and the criteria of inclusion
ere patients with clinical diagnosis, microbiology isolation,
maging and bone biopsy. Exclusion criteria: inmunocompro-
ised and pregnant woman.
Results: 10 patients completed the study; the 88% were
ales, age 19 to 72 years, mean 39 years. The more com-
on location were: hip, femur, tibia, sacrum and calcaneus.
he risk factors identiﬁcated were: open fracture, vascular
ompromise, prolong use of antibiotic, long stay and re-
nterventions. Positive cultures for A. baumannii 100%. They
eceived different regimens of antibiotics without success,
t this time we began with tigecycline IV 100mg the ﬁrst
ay and then 50mg IV q 12hs for 6-7 weeks, all the patients
ncluded a combined surgical and medical management.
Conclusion: 90% showed clinical improvement, and the
